Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-17

FDA Approved: GABAPENTIN — Supplemental Application (Advagen Pharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for gabapentin filed by Advagen Pharma Ltd. The approval updates the approved generic product as part of the supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)